David Perlman

Dr. David Perlman

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Current HIV/AIDS Reports
Verified
Journal Article
Closed access
PDF file
DPDavid Perlman
David Perlman
AJAshly E. Jordan
Ashly E. Jordan

28 March 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
HMHayato Mitaka
Hayato Mitaka
TGTessa Gomez
Tessa Gomez
YLYoung Im Lee
Young Im Lee
DPDavid Perlman
David Perlman
Background: The value of follow-up blood cultures (FUBCs) to document clearance of bacteremia due to Gram-negative bacilli (GNB) has not been well established. Although previous studies suggested that the yield of FUBCs for GNB bacteremia is low, it remains to be elucidated for whom FUBC may be beneficial and for whom it is unnecessary. Methods: A retrospective cohort study was performed at 4 acute care hospitals to identify risk factors for positive FUBCs with GNB bacteremia and to better guide clinicians’ decisions as to which patients may or may not benefit from FUBCs. Participants included adult patients with GNB bacteremia who had FUBCs and were admitted between January 2017 and December 2018. The primary outcomes were the factors associated with positive FUBCs and the yield of FUBCs with and without the factors. Results: Of 306 patients with GNB bacteremia who had FUBCs, 9.2% (95% confidence interval, 6.2%–13.0%) had the same GNB in FUBCs. In the multivariate logistic regression analysis, end-stage renal disease on hemodialysis, intravascular device, and bacteremia due to extended-spectrum β-lactamase or carbapenemase-producing organism were identified as independent predictors of positive FUBCs with GNB bacteremia. Approximately 7 FUBCs and 30 FUBCs were needed for patients with ≥1 or no risk factors, respectively, to yield 1 positive result. SummaryThis multi-site retrospective cohort study found that among patients with gram-negative bacilli (GNB) bacteremia, having ESRD on hemodialysis, intravascular devices, or bacteremia due to multi-drug resistant GNB were each independently associated with having a positive follow-up blood culture. Conclusions: Follow-up blood culture may not be necessary for all patients with GNB bacteremia and has the highest yield in patients with 1 or more risk factors.

1 October 2018 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Open access
CBCzarina N. Behrends
Czarina N. Behrends
ANAnn V. Nugent
Ann V. Nugent
DJDon C. Des Jarlais
Don C. Des Jarlais
JFJemima A. Frimpong
Jemima A. Frimpong
DPDavid Perlman
David Perlman
BSBruce R. Schackman
Bruce R. Schackman

Samuel R. FriedmanSamuel R. Friedman
Samuel R. Friedman
Leslie Denise WilliamsLeslie Denise Williams
Leslie Denise Williams
AJAshly E Jordan
Ashly E Jordan
SWSuzan Walters
Suzan Walters
DPDavid Perlman
David Perlman
JEJerel Ezell
Jerel Ezell
Structural racism is increasingly recognized as a key driver of health inequities and other adverse outcomes. This paper focuses on structural racism as an “upstream” institutionalized process, how it creates health inequities and how structural racism persists in spite of generations of efforts to end it. So far, “downstream” efforts to reduce these health inequities have had little success in eliminating them. Here, we attempt to increase public health awareness of structural racism and its institutionalization and sociopolitical supports so that research and action can address them. This paper presents both a theoretic and an analytic approach to how structural racism contributes to disproportionate rates of HIV/AIDS and related diseases among oppressed populations. We first discuss differences in disease and health outcomes among people who use drugs (PWUD) and other groups at risk for HIV from different racial and ethnic populations. The paper then briefly analyzes the history of racism; how racial oppression, class, gender and other intersectional divisions interact to create health inequities; and how structural racism is institutionalized in ways that contribute to disease disparities among people who use drugs and other people. It examines the processes, institutions and other structures that reinforce structural racism, and how these, combined with processes that normalize racism, serve as barriers to efforts to counter and dismantle the structural racism that Black, indigenous and Latinx people have confronted for centuries. Finally, we discuss the implications of this analysis for public health research and action to undo racism and to enhance the health of populations who have suffered lifetimes of racial/ethnic oppression, with a focus on HIV/AIDS outcomes.


29 April 2022 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
HMHayato Mitaka
Hayato Mitaka
SFShigeki Fujitani
Shigeki Fujitani
TKToshiki Kuno
Toshiki Kuno
DPDavid Perlman
David Perlman
Objective: It remains unclear whether a follow-up blood culture (FUBC) for gram-negative bacilli (GNB) bacteremia should be routinely or selectively performed. To evaluate the value of the practice, we analyzed the association between current FUBC practices and length of stay, antibiotic treatment duration, and in-hospital mortality.Design: Retrospective cohort study.Setting: The study was conducted in 4 acute-care hospitals in New York City.Patients: The study included hospitalized adults with GNB bacteremia between 2017 and 2018.Methods: An FUBC was defined as a blood culture performed between 24 hours and 7 days after an initial blood culture positive for GNB. Using propensity scores for FUBCs performed, patients were matched 1:1 for outcome comparison.Results: In total, 376 hospitalized adults with GNB bacteremia met eligibility criteria. Among them, FUBCs were performed in 271 patients (72%). After propensity score matching, we analyzed 87 pairs of patients with and without an FUBC to compare outcomes. The median length of stay was longer among patients with FUBCs than patients without FUBCs (9 days vs 7 days; P = .017). The median duration of antibiotic treatment was also longer among patients with FUBCs than patients without FUBCs (8 vs 6 days; P = .007). No statistically significant difference was observed in in-hospital mortality between patients with and without an FUBC (odds ratio, 0.37; 95% confidence interval, 0.08–1.36).Conclusions: Current FUBC practices for GNB bacteremia were associated with prolonged length of stay and duration of antibiotic treatment. Further data to better inform selectivity criteria for FUBCs in GNB bacteremia are needed.